Salem Capital Management Inc Merck & Co., Inc. Transaction History

Salem Capital Management Inc

$126 Million
Q3 2022

A detailed history of Salem Capital Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Salem Capital Management Inc holds 81,739 shares of MRK stock, worth $8.16 Million. This represents 5.57% of its overall portfolio holdings.

Number of Shares

81,739

Previous 81,605 0.16%

Holding current value

$8.16 Million

Previous $7.44 Million 5.39%

% of portfolio

5.57%

Previous 5.42%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 29, 2022	BUY	$84.53 - $94.96 $11,327 - $12,724	134 Added 0.16%	81,739 $7.04 Million
Q2 2022 Jul 27, 2022	SELL	$83.49 - $94.64 $448,007 - $507,838	-5,366 Reduced 6.17%	81,605 $7.44 Million
Q1 2022 Apr 07, 2022	SELL	$73.51 - $82.4 $55,132 - $61,800	-750 Reduced 0.85%	86,971 $7.14 Million
Q4 2021 Jan 18, 2022	SELL	$72.28 - $90.54 $68,666 - $86,013	-950 Reduced 1.07%	87,721 $6.72 Million
Q3 2021 Oct 12, 2021	SELL	$71.68 - $78.83 $129,024 - $141,894	-1,800 Reduced 1.99%	88,671 $6.66 Million
Q2 2021 Jul 13, 2021	BUY	$70.31 - $77.77 $235,538 - $260,529	3,350 Added 3.85%	90,471 $7.04 Million
Q1 2021 Apr 15, 2021	BUY	$68.86 - $81.11 $473,412 - $557,631	6,875 Added 8.57%	87,121 $6.72 Million
Q4 2020 Jan 12, 2021	SELL	$71.77 - $79.65 $77,511 - $86,022	-1,080 Reduced 1.33%	80,246 $6.56 Million
Q3 2020 Oct 13, 2020	SELL	$73.18 - $82.95 $307,795 - $348,887	-4,206 Reduced 4.92%	81,326 $6.75 Million
Q2 2020 Jul 20, 2020	SELL	$70.42 - $80.13 $4,225 - $4,807	-60 Reduced 0.07%	85,532 $6.61 Million
Q1 2020 Apr 14, 2020	SELL	$63.36 - $87.82 $427,680 - $592,785	-6,750 Reduced 7.31%	85,592 $6.59 Million
Q4 2019 Jan 09, 2020	SELL	$77.58 - $87.54 $178,434 - $201,342	-2,300 Reduced 2.43%	92,342 $8.4 Million
Q3 2019 Oct 07, 2019	SELL	$76.08 - $82.93 $538,266 - $586,729	-7,075 Reduced 6.96%	94,642 $7.97 Million
Q2 2019 Jul 09, 2019	SELL	$69.84 - $81.59 $380,628 - $444,665	-5,450 Reduced 5.09%	101,717 $8.53 Million
Q1 2019 Apr 15, 2019	SELL	$69.58 - $79.36 $209,366 - $238,794	-3,009 Reduced 2.73%	107,167 $8.91 Million
Q4 2018 Jan 08, 2019	SELL	$65.24 - $75.71 $47,038 - $54,586	-721 Reduced 0.65%	110,176 $8.42 Million
Q3 2018 Oct 09, 2018	SELL	$57.69 - $67.84 $115,206 - $135,476	-1,997 Reduced 1.77%	110,897 $7.87 Million
Q2 2018 Jul 09, 2018	SELL	$50.83 - $59.72 $30,498 - $35,832	-600 Reduced 0.53%	112,894 $6.85 Million
Q1 2018 Apr 09, 2018	BUY	$50.96 - $59.23 $54,782 - $63,672	1,075 Added 0.96%	113,494 $6.18 Million
Q4 2017 Jan 16, 2018	SELL	$51.62 - $61.64 $101,433 - $121,122	-1,965 Reduced 1.72%	112,419 $6.33 Million
Q3 2017 Oct 10, 2017	BUY	$58.67 - $63.13 $6.71 Million - $7.22 Million	114,384	114,384 $7.32 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.

Account

Salem Capital Management Inc Merck & Co., Inc. Transaction History